The EXCITE International Executive Board

EXCITE International is governed by an Executive Board drawn from the worldwide community of healthcare thought leaders, corporate executives and innovators.


Richard Kuntz, EXCITE International Executive Board

Richard E. Kuntz, MD

Rick is Senior Vice President and Chief Scientific, Clinical and Regulatory Officer of Medtronic, Inc. and Chair of the Board of EXCITE International. 
» More


Dr. Carl Christian Gilhuus-Moe, EXCITE International Executive Board

Carl C. Gilhuus-Moe, PhD

Dr. Gilhuus-Moe is Chairman of the Board of Norway Health Tech and Senior Advisor of NeoMed focused on international healthcare and medical technology.
» More


Rafi Hofstein, EXCITE International Executive Board

Rafi Hofstein, PhD

Dr. Raphael Hofstein is the President and CEO of MaRS Innovation, having joined the organization in 2009.  » More

Anne Kolbe, EXCITE International Executive Board

Anne Kolbe, MBBS

Anne Kolbe is a paediatric surgeon with 30 years' clinical experience in the public and private health systems of New Zealand, Australia and the USA.
» More


Mark Leahey, EXCITE International Advisory Council

Mark Leahey

Mark is the President & CEO for the Medical Device Manufacturers Association (MDMA).
» More



Dr. Leslie Levin, EXCITE International Executive Board

Leslie Levin, MD

Dr. Levin is the Founder and Chief Executive and Scientific Officer of EXCITE International and an international leader in creating transformational change. » More


Dr. Jeffrey Popma, EXCITE International Executive Board

Jeffrey Popma, MD

Dr. Popma, is Professor of Medicine at Harvard Medical School and Chief Scientific Officer at the Baim Clinical Research Institute in Boston. » More


Dr. Sean Tunis, EXCITE International Executive Board

Sean R. Tunis, MD

Dr. Sean Tunis is President and Chief Executive Officer of the independent nonprofit Center for Medical Technology Policy (CMTP). » More


EXECUTIVE COMMITTEE PRIVATE AREA | LOGIN  

Work with us. EXCITE International can assist you in facilitating multi-jurisdictional clinical trials through its partnership with government, clinical experts, methodology centres and health system decision makers.